NLRP3 attenuates intraocular inflammation by inhibiting AIM2 mediated pyroptosis through the P-SIK1/SREBF1 pathway.
Jiayu MengNa LiXianyang LiuShengjun QiaoQian ZhouJun TanTing ZhangZhifang DongXiaopeng QiAize KijlstraLiming MaoPeizeng YangShengping HouPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
Our data show that NLRP3 inhibits AIM2 inflammasome mediated EAU by regulating the P-SIK1/SREBF1 pathway, highlighting the therapeutic potential of targeting Nlrp3. This article is protected by copyright. All rights reserved.